PCSA (Processa Pharma) Pangali Forward P/E

Processa Pharmaceuticals (PCSA) is competing in the oncology sector by developing modified drugs. The company focuses on treating solid tumors by optimizing therapy biodistribution. The unique redesign of legacy drugs provides patent protection and premium pricing power. The company's forward P/E ratio history reflects the dynamics of market valuations, with the metric settling at 0.00.

PCSA - Pangali Forward P/E processapharmaceuticals.com ing rentang 04.07.2022 - 10.11.2026

Rincian metrik lan analitis perusahaan Processa Pharma (PCSA)

- rega saiki lan proyeksi nilai saham:

Kutipan saham Processa Pharmaceuticals|PCSA - Konsensus nilai wajar

- indikator valuasi pasar bisnis:

Kapitalisasi pasar Processa Pharmaceuticals Inc.|PCSA - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- informasi kapitalisasi buku:

Nilai Buku saben Saham Processa Pharmaceuticals|PCSA - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku processapharmaceuticals.com|PCSA - Total Aset Bisnis

- indikator beban kredit lan likuiditas emiten:

Total Utang marang Modal Processa Pharmaceuticals|PCSA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Processa Pharmaceuticals|PCSA - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Processa Pharmaceuticals Inc.|PCSA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Processa Pharmaceuticals|Likuiditas cepet processapharmaceuticals.com

- statistik bathi lan rasio pasar:

PCSA - Bathi pungkasan|Bathi sing dikarepake Processa Pharmaceuticals|PCSA - Kapitalisasi marang bathi|Pangali Forward P/E Processa Pharmaceuticals|PCSA - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Processa Pharmaceuticals Inc.|PCSA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Processa Pharmaceuticals|PCSA - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan processapharmaceuticals.com|PCSA - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Processa Pharmaceuticals

Analisis kabeh metrik perusahaan:PCSA Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals (PCSA) bases its strategy on expanding into the solid tumor therapy segment by optimizing drug biodistribution for oncology patients. An analysis of the business's forward P/E allows for the correlation of current market capitalization with expected annual earnings, determining the asset's degree of overvaluation and forming a consensus regarding the company's long-term investment attractiveness.

Pesaing langsung

Prakiraan rega marang bathi OLMA (Olema)|PBYI (pumabiotechnology.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E GLSI (Greenwich LifeSciences, Inc)|ZNTL - Prakiraan rega marang bathi|MacroGenics, Inc. - Pangali Forward P/E|PSTV - Pangali Forward P/E|eagleus.com (EGRX) - Rega marang bathi mangsa ngarep